Evidence map›Paper›PMID 39062925›Full record

ArticleInternational journal of molecular sciences2024

Investigation of the Genetic Determinants of Telangiectasia and Solid Organ Arteriovenous Malformation Formation in Hereditary Hemorrhagic Telangiectasia (HHT).

Kevin J Whitehead, Doruk Toydemir, Whitney Wooderchak-Donahue, Gretchen M Oakley, Bryan McRae, Angelica Putnam, Jamie McDonald, Pinar Bayrak-Toydemir

Abstract read
In one paragraph

Article in International journal of molecular sciences, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Review
  11. Case report: Novel homozygousFrontiers in genetics · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Kevin J WhiteheadDivision of Cardiovascular Medicine, Department of Medicine, University of Utah, Salt Lake City, UT 84112, USA.ORCID 0000-0003-0419-7309
Doruk ToydemirSchool of Liberal Arts, Tulane University, New Orleans, LA 70118, USA.ORCID 0009-0008-2853-5062
Whitney Wooderchak-DonahueDepartment of Pathology, University of Utah, Salt Lake City, UT 84112, USA.
Gretchen M OakleyDepartment of Otolaryngology-Head and Neck Surgery, University of Utah, Salt Lake City, UT 84112, USA.
Bryan McRaeDepartment of Otolaryngology-Head and Neck Surgery, University of Utah, Salt Lake City, UT 84112, USA.
Angelica PutnamDepartment of Pathology, University of Utah, Salt Lake City, UT 84112, USA.
Jamie McDonaldDepartment of Pathology, University of Utah, Salt Lake City, UT 84112, USA.ORCID 0000-0001-9939-7922
Pinar Bayrak-ToydemirDepartment of Pathology, University of Utah, Salt Lake City, UT 84112, USA.ORCID 0000-0001-9381-2478

Funding

University of Utah CGM/UGP Award
6 · The paper itself

Abstract

Telangiectases and arteriovenous malformations (AVMs) are the characteristic lesions of Hereditary Hemorrhagic Telangiectasia (HHT). Somatic second-hit loss-of-function variations in the HHT causative genes,

Indexed as

Arteriovenous MalformationsTelangiectasia, Hereditary HemorrhagicActivin Receptors, Type IIAdultAgedEndoglinFemaleHigh-Throughput Nucleotide SequencingHumansMaleMiddle AgedMutationTelangiectasisActivin Receptors, Type IIACVRL1 protein, humanEndoglinENG protein, humanAVMbiallelichereditary hemorrhagic telangiectasiasomatictelangiectasiatissue

Identifiers

PMID39062925
PMCPMC11276621

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.